Influence of surfactant on pulmonary inflammatory response and release of elastase in experimental neonatal group B streptococcal pneumonia;Einfluss von Surfactant auf das pulmonale Entzundungsgeschehen und die Elastasefreisetzung bei experimenteller neonataler B-Streptokokken-Pneumonie

Monatsschrift fur Kinderheilkunde

Volumn 144, Issue 12, 1996, Pages 1319-1325

  Herting, E ^a,b   Speer, C P ^a,b   Sun, B ^a,b   Jarstrand, C ^a,b   Curstedt, T ^a,b   Robertson, B ^a,b  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b NONE

Author keywords

group B streptococci; neutrophil elastase; pneumonia; surfactant

Indexed keywords

ELASTASE; LUNG SURFACTANT EXTRACT; SURFACTANT;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL GROWTH; CONTROLLED STUDY; ENZYME ACTIVITY; INFLAMMATION; NONHUMAN; PNEUMONIA; RABBIT; STREPTOCOCCUS AGALACTIAE;

EID: 0030465787     PISSN: 00269298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001120050088     Document Type: Article

References (45)

1. Ablow R, Driscoll S, Effmann E, Gross I, Jolies CJ, Uauy R, Warshaw JL (1976) A comparison of early onset group B streptococcal neonatal infection and the respiratory distress syndrome. N Engl J Med 294: 65-70
2. Auten RL, Notter RH, Kendig JW, Davis JM, Shapiro DL (1991) Surfactant treatment of full-term newborns with respiratory failure. Pediatrics 87: 101-107
3. Baker CJ, Edwards MS (1988) Group B streptococcal infections. Perinatal impact and prevention methods. Ann N Y Acad Sci 549: 193-202
4. Bartmann P (1993) Immunreaktionen im Rahmen der Surfactant-Substitutions-Therapie. In: Wauer RR (Hrsg) Surfactant-therapie des neonatalen Atemnotsyndroms. Thieme, Stuttgart New York, S 67-81
5. Brehmer U, Jorch G (1993) Surfactant-therapie bei 41 Frühgeborenen <34 SSW mit Verdacht auf konnatale Infektion (Fallkontrollanalyse). Klin Padiatr 205: 78-82
6. Bruce M, Boat T, Martin R, Dearborn D, Fanaroff A (1982) Proteinase inhibitors and inhibitor inactivation in neonatal airway secretions. Chest 8: 44-45
7. Bruce MC, Schuyler M, Martin RJ, Starcher BC, Tomashefski JF, Wedig KE (1992) Risk factors for the degradation of lung elastic fibers in the ventilated neonate. Am Rev Respir Dis 146: 204-212
8. Cockshutt AM, Weitz J, Possmayer F (1990) Pulmonary surfactant-associated protein A enhances the surface activity of lipid extract surfactant and reverses inhibition by blood proteins in vitro. Biochemistry 29: 8424-8429
9. Collaborative European muiticenter study group (1988) Surfactant replacement therapy for severe neonatal respiratory distress syndrome: an international randomized clinical trial. Pediatrics 82: 683-691
10. Committee on infectious diseases and committee on fetus and newborn (1992) Guidelines for prevention of group B streptococcal (GBS) infection by chemoprophylaxis. Pediatrics 90: 775-778
11. Curstedt T, Johansson J, Robertson B, Persson P, Löwenadler B, Jörnvall H (1993) Structure and function of hydrophobic surfactant-associated proteins. In: Bevilacqua G, Parmigiani S, Robertson B (eds) Surfactant in clinical practice. Harwood Academic Publishers, Chur. pp 55-60
12. Gerdes J, Whitsett J, Long W (1992) Elastase activity and surfactant protein concentration in tracheal aspirates from neonates receiving synthetic surfactant J Pediatr 120: 34-39
13. Gortner L, Pohlandt F, Bartmann P (1990) Wirkung eines bovinen Surfactants bei sehr kleinen Frühgeborenen mit konnataler Pneumonie. Monatschr Kinderheilkd 138: 274-278
14. Griese M (1992) Lungensurfactant und Immunsystem. Monatsschr Kinderheilkd 140: 57-61
15. Håkansson S, Bergholm AM, Holm SE, Wagner B, Wagner M (1988) Properties of high and low density subpopulations of group B streptococci: enhanced virulence of the low density variant. Microb Pathog 5: 345-355
16. Håkansson S, Granlund-Edstedt M, Sellin M, Holm SE (1990) Demonstration and characterization of buoyant-densitv subpopulations of group B streptococcus typ III. J Infect Dis 161: 741-746
17. Hall SL, Sherman MP (1992) Intrapulmonary bacterial clearance of type III group B streptococcus is reduced in preterm compared with term rabbits and occurs independent of antibody. Am Rev Respir Dis 145: 1172-1177
18. Herting E, Harms K, Speer CP and members of the Collaborative European multicenter study group (1991) Incidence of neonatal infections in very low birth weight infants with severe RDS treated with a natural porcine surfactant. Biol Neonate 59: 382-383
19. Herting E, Jarstrand C, Rasool O, Curstedt T, Sun B, Robertson B (1994) Experimental neonatal group B streptococcal pneumonia: effect of a modified porcine surfactant on bacterial proliferation in ventilated near-term rabbits. Pediatr Res 36: 784-791
20. Herting E, Jarstrand C, Rasool O, Curstedt T, Håkansson S, Robertson B (1995) Effect of surfactant on nitroblue tetrazolium (NBT) reduction of polymorphonuclear leucocytes stimulated with type la group B streptococci. Acta Paediatr 84: 922-926
21. Jarstrand C, Berggren P, Curstedt T, Johansson A, Robertson B, Wiernik A (1984) Influence of lung surfactant phospholipids on neutrophilic granulocytes and blood monocytes. Prog Respir Res 18: 44-50
22. Jelinkovà J (1977) Group B streptococci in the human population. Curr Top Microbiol Immunol 76: 126-165
23. Lotze A, Knight GR, Martin GR, Bulas DI, Hull WM, O'Donnell RM, Whitsett JA, Short BL (1993) Improved pulmonary outcome after exogenous surfactant therapy for respiratory failure in term infants requiring extracorporeal membrane oxygenation. J Pediatr 122: 261-268
24. 1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. J Clin Invest 72: 656-666
25. Merritt TA, Hallman M, Holcomb K (1986) Human surfactant treatment of severe respiratory distress syndrome: pulmonary effluent indicators of lung inflammation. J Pediatr 108: 741-748
26. Ogden BE, Murphy SA, Saunders GC, Pathak D, Johnson ID (1984) Neonatal lung neutrophils and elastase/proteinase inhibitor imbalance. Am Rev Respir Dis 130: 817-821
27. Pison U, Tam EK, Caughey GH, Hawgood S (1989) Proteolytic inactivation of dog lung surfactant-associated proteins by neutrophil elastase. Biochim Biophys Acta 992: 251-257
28. Rider ED, Jobe AH, Ikegami M, Sun B (1992) Different ventilation strategies alter surfactant responses in preterm rabbits. J Appl Physiol 73: 2089-2096
29. Robertson B, Berry D, Curstedt T, Grossmann G. Ikegami M, Jacobs H, Jobe A (1985) Leakage of protein in the immature rabbit lungs: Effects of surfactant replacement. Respir Physiol 61: 265-276
30. Sherman M, D'Ambola J, Aeberhard E, Barrett CT (1988) Surfactant therapy of newborn rabbits impairs lung macrophage bactericidal activity. J Appl Physiol 65: 137-145
31. Sherman MP, Johnson HT, Rothlein R, Hughes BJ, Smith WC, Anderson DC (1992) Role of pulmonary phagocytes in host defense against group B streptococci in preterm versus term rabbit lung. J Infect Dis 166: 818-826
32. Sherman MP, Campbell LA, Merritt TA, Long WA, Gunkel HJ, Curstedt T (1994) Effect of different surfactants on pulmonary group B streptococcal infection in premature rabbits. J Pediatr 125: 939-947
33. Shigeoka AO, Hall RT, Hemming VG, Allred CD, Hill HR (1978) Role of antibody and complement in opsonization of group B streptococci. Infect Immun 21: 34-40
34. 1-proteinase inhibitor in early diagnosis of neonatal septicemia. J Pediatr 108: 987-990
35. Speer CP, Götze B, Robertson B, Curstedt T (1991) The effect of natural porcine surfactant (Curosurf) on the phagocytosis-associated functions of human neutrophils. In: Cosmi EV, Di Renzo CC, Anceschi MM (eds) The surfactant system of the lung. Prevention and treatment of neonatal and adult respiratory distress syndrome. Macmillan, London, pp 142-150
36. Speer CP, Götze B, Curstedt T, Robertson B (1991) Phagocytic function and TNF secretion of human monocytes exposed to natural porcine surfactant (Curosurf). Pediatr Res 30: 69-74
37. Speer CP, Reuss D, Harms K, Herting E, Gefeller O (1993) Neutrophil elastase and acute pulmonary damage in neonates with severe respiratory distress syndrome. Pediatrics 91: 794-799
38. Sun B, Kobayashi T, Curstedt T, Grossmann G. Robertson B (1991) Application of a new ventilator-multi-plethysmograph system for testing efficacy of surfactant replacement in newborn rabbits. Eur Respir J 4: 364-370
39. Tegtmeyer FK, Möller J, Richter A, Wilken B, Fischer TH (1994) Plasma concentration of elastase-α-proteinase inhibitor complex in surfactant-treated preterm neonates with respiratory distress syndrome. Eur Respir J 7: 260-264
40. Van Iwaarden JF, Welmers B, Verhoef J, Haagsman HP, Golde LMG van (1990) Pulmonary surfactant protein A enhances the host-defense mechanism of rat alveolar macrophages. Am J Respir Cell Mol Biol 2: 91-98
41. Van Iwaarden JF, Shimizu H, Golde PHM van, Voelker DR, Golde LMG van (1992) Rat surfactant protein D enhances the production of oxygen radicals by rat alveolar macrophages. Biochem J 286: 5-8
42. Van Iwaarden JF (1993) Surfactant and the pulmonary defense system. In: Robertson B, Golde LMG van, Batenburg JJ (eds) Pulmonary surfactant. From molecular biology to clinical practice. Elsevier, Amsterdam New York, pp 215-225
43. Walti H, Tordet C, Gerbaut L, Saugier P, Moriette G, Relier JP (1989) Persistent elastase/proteinase inhibitor imbalance during prolonged ventilation of infants with bronchopulmonary dysplasia: evidence for the role of nosocomial infections. Pediatr Res 26: 351-355
44. Weissman LE, Stoll BJ, Cruess DF, Hall RT Merenstein GB, Hemming VG, Fischer GW (1992) Early onset group B-streptococcal sepsis: a current assessment. J Pediatr 121: 428-433
45. Yasutake A, Powers JC (1981) Reactivity of human leukocyte elastase an porcine pancreatic elastase toward peptide 4-nitroanilides containing model desmosine residues: evidence that human leukocyte elastase is selective for cross-linked regions of elastin. Biochemistry 20: 3675-3679